Core Insights - Tilray Brands has secured a licensing agreement with Carlsberg Group to produce, market, and sell Carlsberg's beer portfolio in the U.S., starting in 2027 with a five-year term and an option for renewal based on performance [1][2]. Group 1: Agreement Details - The agreement encompasses Carlsberg's flagship beer and other brands such as Carlsberg Elephant, 1664, and Kronenbourg 1664 Blanc [2]. - The automatic renewal option for another five years is contingent on meeting specific performance criteria [2]. Group 2: Market Positioning - Tilray aims to enhance Carlsberg's market share in the U.S. and capitalize on the growing consumer interest in premium and imported beers [3]. - Despite a decline in overall beer consumption and a shift away from craft beers impacting earnings, Tilray identifies opportunities within the premium segment [3]. Group 3: Company Strategy and Performance - Tilray's CEO emphasized the importance of partnerships with top brands to maximize beverage operations value [4]. - The company has expanded its beverage portfolio by acquiring 12 brands in 2023 and 2024, including eight from Anheuser-Busch and four from Molson Coors [4]. - Tilray holds a 60% market share in the North American THC drinks market, which continues to grow despite regulatory uncertainties [5]. - In its latest earnings report, Tilray reported a 3% increase in net revenue to $217.5 million, with cannabis sales also up by 3% to $67.5 million, while beverage net revenue decreased by 20% to $50.1 million compared to the previous year [5].

February 18, 2026 Danish brewing giant Carlsberg A/S is considering an initial public offering (IPO) for its Indian business as it seeks to unlock shareholder value amid rising sales and strong market performance. Group CEO Jacob Aarup-Andersen confirmed the company’s intent to explore a listing on Indian bourses but stressed that no final decision has been taken.Speaking during a recent investor call, Andersen acknowledged prolonged speculation around the plans and said the company is evaluating whether a ...